These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 12187077)
21. Non-malignant and tumor-derived cells differ in their requirement for p27Kip1 in transforming growth factor-beta-mediated G1 arrest. Donovan JC; Rothenstein JM; Slingerland JM J Biol Chem; 2002 Nov; 277(44):41686-92. PubMed ID: 12202478 [TBL] [Abstract][Full Text] [Related]
22. Molecular mechanisms of ZD1839-induced G1-cell cycle arrest and apoptosis in human lung adenocarcinoma A549 cells. Chang GC; Hsu SL; Tsai JR; Liang FP; Lin SY; Sheu GT; Chen CY Biochem Pharmacol; 2004 Oct; 68(7):1453-64. PubMed ID: 15345335 [TBL] [Abstract][Full Text] [Related]
23. A flavonoid antioxidant, silymarin, inhibits activation of erbB1 signaling and induces cyclin-dependent kinase inhibitors, G1 arrest, and anticarcinogenic effects in human prostate carcinoma DU145 cells. Zi X; Grasso AW; Kung HJ; Agarwal R Cancer Res; 1998 May; 58(9):1920-9. PubMed ID: 9581834 [TBL] [Abstract][Full Text] [Related]
24. Lactoferrin inhibits G1 cyclin-dependent kinases during growth arrest of human breast carcinoma cells. Damiens E; El Yazidi I; Mazurier J; Duthille I; Spik G; Boilly-Marer Y J Cell Biochem; 1999 Sep; 74(3):486-98. PubMed ID: 10412049 [TBL] [Abstract][Full Text] [Related]
25. Differential effects of transforming growth factor on cell cycle regulatory molecules in human myeloid leukemia cells. Hu X; Zhang X; Zhong Q; Fisher AB; Bryington M; Zuckerman KS Oncogene; 2001 Oct; 20(47):6840-50. PubMed ID: 11687963 [TBL] [Abstract][Full Text] [Related]
26. The subcellular locations of p15(Ink4b) and p27(Kip1) coordinate their inhibitory interactions with cdk4 and cdk2. Reynisdóttir I; Massagué J Genes Dev; 1997 Feb; 11(4):492-503. PubMed ID: 9042862 [TBL] [Abstract][Full Text] [Related]
27. TGF-beta induced G(1) cell cycle arrest requires the activity of the proteasome pathway. Transforming growth factor. Zhang F; Mönkkönen M; Roth S; Laiho M Exp Cell Res; 2002 Dec; 281(2):190-6. PubMed ID: 12460649 [TBL] [Abstract][Full Text] [Related]
28. TGF-beta 1 induces the cyclin-dependent kinase inhibitor p27Kip1 mRNA and protein in murine B cells. Kamesaki H; Nishizawa K; Michaud GY; Cossman J; Kiyono T J Immunol; 1998 Jan; 160(2):770-7. PubMed ID: 9551912 [TBL] [Abstract][Full Text] [Related]
29. Differential responses of skin cancer-chemopreventive agents silibinin, quercetin, and epigallocatechin 3-gallate on mitogenic signaling and cell cycle regulators in human epidermoid carcinoma A431 cells. Bhatia N; Agarwal C; Agarwal R Nutr Cancer; 2001; 39(2):292-9. PubMed ID: 11759294 [TBL] [Abstract][Full Text] [Related]
30. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity. Coppock DL; Buffolino P; Kopman C; Nathanson L Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260 [TBL] [Abstract][Full Text] [Related]
32. Ginsenoside Rh2-mediated G1 phase cell cycle arrest in human breast cancer cells is caused by p15 Ink4B and p27 Kip1-dependent inhibition of cyclin-dependent kinases. Choi S; Kim TW; Singh SV Pharm Res; 2009 Oct; 26(10):2280-8. PubMed ID: 19629651 [TBL] [Abstract][Full Text] [Related]
33. Troglitazone induces p27Kip1-associated cell-cycle arrest through down-regulating Skp2 in human hepatoma cells. Koga H; Harada M; Ohtsubo M; Shishido S; Kumemura H; Hanada S; Taniguchi E; Yamashita K; Kumashiro R; Ueno T; Sata M Hepatology; 2003 May; 37(5):1086-96. PubMed ID: 12717389 [TBL] [Abstract][Full Text] [Related]
34. Mechanisms of cell cycle arrest in response to TGF-beta in progestin-dependent and -independent growth of mammary tumors. Salatino M; Labriola L; Schillaci R; Charreau EH; Elizalde PV Exp Cell Res; 2001 Apr; 265(1):152-66. PubMed ID: 11281653 [TBL] [Abstract][Full Text] [Related]
35. Cell cycle arrest induced by the vitamin D(3) analog EB1089 in NCI-H929 myeloma cells is associated with induction of the cyclin-dependent kinase inhibitor p27. Park WH; Seol JG; Kim ES; Jung CW; Lee CC; Binderup L; Koeffler HP; Kim BK; Lee YY Exp Cell Res; 2000 Feb; 254(2):279-86. PubMed ID: 10640426 [TBL] [Abstract][Full Text] [Related]
36. Gefitinib ('Iressa', ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor, up-regulates p27KIP1 and induces G1 arrest in oral squamous cell carcinoma cell lines. Shintani S; Li C; Mihara M; Yano J; Terakado N; Nakashiro K; Hamakawa H Oral Oncol; 2004 Jan; 40(1):43-51. PubMed ID: 14662414 [TBL] [Abstract][Full Text] [Related]
37. Enhancement of the p27Kip1-mediated antiproliferative effect of trastuzumab (Herceptin) on HER2-overexpressing tumor cells. Marches R; Uhr JW Int J Cancer; 2004 Nov; 112(3):492-501. PubMed ID: 15382077 [TBL] [Abstract][Full Text] [Related]
38. Erlotinib, an effective epidermal growth factor receptor tyrosine kinase inhibitor, induces p27KIP1 up-regulation and nuclear translocation in association with cell growth inhibition and G1/S phase arrest in human non-small-cell lung cancer cell lines. Ling YH; Li T; Yuan Z; Haigentz M; Weber TK; Perez-Soler R Mol Pharmacol; 2007 Aug; 72(2):248-58. PubMed ID: 17456787 [TBL] [Abstract][Full Text] [Related]
39. Formation of p27-CDK complexes during the human mitotic cell cycle. Soos TJ; Kiyokawa H; Yan JS; Rubin MS; Giordano A; DeBlasio A; Bottega S; Wong B; Mendelsohn J; Koff A Cell Growth Differ; 1996 Feb; 7(2):135-46. PubMed ID: 8822197 [TBL] [Abstract][Full Text] [Related]